Reviews

Musely / The Body Cream

A compounded 12% hydroquinone body cream sold on subscription. That is three times the standard prescription strength, on the largest surface area on the body, for as long as you keep paying. The number is not on the product page.

There is a real reason to hesitate. Read the finding before you buy.

Musely / The KP Cream

Three different formulas are sold under one name and one price. One of them is a textbook keratosis pilaris treatment. One adds a topical steroid to an open-ended subscription. One drops the keratolytics entirely and treats a hyperkeratosis with two immunomodulators. Which you are prescribed decides the answer.

Worth buying for a specific person with a specific problem. Read who.

Musely / The Acne Cream

A retinoid plus a topical antibiotic is a combination the AAD explicitly recommends, and at $30 a month this is the best value Musely sells. What is missing is the benzoyl peroxide that keeps the antibiotic working — and there is no end date on the subscription.

Worth buying for a specific person with a specific problem. Read who.

Musely / The Spot Pill

The best-evidenced thing Musely sells, at the exact dose the network meta-analysis identifies as optimal. It is also the only one that is systemic — and its safety case rests entirely on screening that is advertised as a three-minute online visit.

Worth buying for a specific person with a specific problem. Read who.

Musely / The Spot Peel

The same 12% hydroquinone as the Body Cream, and this time the number is far less alarming — one application every three to six months, washed off. The problem is different: this is an inflammatory peel sold to treat melasma, and inflammation is what makes melasma come back.

There is a real reason to hesitate. Read the finding before you buy.

Musely / The Anti-Aging Cream

Three ingredients, all of them working, at doses that are all inside the therapeutic range — with a real titration ladder from 0.025% to 0.1%. After five reviews of underdosed formulas, this is the one that is simply correct. Ignore the 30-day claim.

Buy it. The formula, the disclosure and the price all hold up.

Musely / The Private Cream

Hydroquinone up to 12%, marketed for the underarm, groin, genital and perianal areas. Scrotal skin absorbs roughly forty-two times what forearm skin does. One concentration is being sold across sites that differ that much, and nothing on the page adjusts for it.

We would not buy this, and we say why.

Musely / The Eye Serum

The page sells prescription tretinoin as up to twenty times more potent than retinol. The formula contains tretinoin at 0.001%. Apply the company's own multiplier to the company's own concentration and it lands well below a supermarket retinol.

There is a real reason to hesitate. Read the finding before you buy.

Musely / The Hair Pill

Three systemic drugs in one compounded pill, sold to women. One of them is dutasteride, which the label says is contraindicated in women of childbearing potential and not indicated for use in women at all. No doses are published for any of them.

We would not buy this, and we say why.

CoreAge Rx / Bounce Back

Copper peptide at 0.2% — four times the concentration used in the best controlled study we could find, and the best-dosed single active we have assessed. Compounded in the US, dispensed after a physician review, positioned for night-time barrier work. The full ingredient list is still not published.

Buy it. The formula, the disclosure and the price all hold up.

CoreAge Rx / Pore Favor

Salicylic acid, zinc oxide, niacinamide and urea — a coherent, well-matched stack for oily, congested skin, compounded and dispensed after a physician review at $42 a month. Everything in it sits inside over-the-counter limits as published, and not one concentration is given.

Worth buying for a specific person with a specific problem. Read who.

CoreAge Rx / Time Out

Every active quantified — estriol 0.3%, vitamin C 5%, hydrolysed hyaluronic acid 0.5% — with the estriol matched exactly to the concentration used in the pivotal topical pilot. A real prescription for a real hormone, which is also why the contraindications below matter more than anything else on this page.

Worth buying for a specific person with a specific problem. Read who.

CoreAge Rx / Smooth Move

Real tretinoin, correctly paired with niacinamide — the best-evidenced construction in topical anti-ageing — at $42 a month with the prescriber, the compounding and delivery included. What the page still will not say is how much tretinoin, and it does not carry the pregnancy contraindication. We do, below.

Buy it. The formula, the disclosure and the price all hold up.

CoreAge Rx / Spot On

Hydroquinone, kojic acid and niacinamide — three complementary routes to the same pigment, with the strongest depigmenting agent in general use at the centre of it. Two things the page leaves out and you should insist on: the hydroquinone percentage, and a stop date. This is a cycled therapy.

Worth buying for a specific person with a specific problem. Read who.

Agency / Future Formula

The first product in this register to publish its inactive ingredients, disclose its side effects, and carry a pregnancy warning on a retinoid page. The concentrations are still not stated up front — but here, unusually, there is a defensible reason.

Worth buying for a specific person with a specific problem. Read who.

Agency / Dark Spot Formula

The subscription cycles the hydroquinone off for you — two to three months on, then two months on a hydroquinone-free formula, switched automatically. After sixteen reviews of courses sold as open-ended subscriptions, somebody finally built the break into the billing.

Worth buying for a specific person with a specific problem. Read who.

Agency / Eye Formula

An anhydrous, preservative-light base for the thinnest skin on the body, and the most specific application instruction in this register — avoid your upper eyelids. It also claims to brighten dark circles with no pigment active in it.

Worth buying for a specific person with a specific problem. Read who.

Curology / DayPrimeRx

A prescription acne treatment that is also a genuine blurring primer, and the optical agents are right there in the published ingredient list. Two things to know: there is no benzoyl peroxide anywhere in the system, and one candidate active is prohibited in EU cosmetics.

Worth buying for a specific person with a specific problem. Read who.

Dermatica / Anti-Ageing Treatment

The first personalised prescription formula in this register to print its concentrations on the page you buy from — tretinoin 0.025–0.1%, hydroquinone 4%, niacinamide 4%. The same page contains no side effects, no contra-indications and no pregnancy warning. The $39.99 cosmetic two clicks away has all three.

Worth buying for a specific person with a specific problem. Read who.

Dermatica / Melasma Treatment

The candidate pool is hydroquinone 4%, tretinoin 0.025–0.1% and fluocinolone acetonide 0.01% — the exact composition of the only melasma product the FDA has ever approved, published in numbers, for $29.95 a month. That product is licensed for eight weeks. This one is sold with a twelve-month prepay and no end date on the page.

Worth buying for a specific person with a specific problem. Read who.

Honeydew / Low Dose Accutane

The first page here to lead with a teratogenicity warning in the regulator's own words, disclose its own off-label status unprompted, and explain the FDA risk programme it operates under. It is also a four-month membership for a course the same page says runs eighteen to twenty-four months.

Worth buying for a specific person with a specific problem. Read who.

Dermatica / Skin Glow Treatment

Two candidate actives — tretinoin 0.025–0.1% and azelaic acid 4–20% — and they are the right two. No hydroquinone, no steroid, nothing with a clock on it. The restraint is real and deliberate. The question is why a prescription consultation is the route to a complaint the page attributes to stress and lack of sleep.

Worth buying for a specific person with a specific problem. Read who.

Dermatica / Weight Loss Skin Support

The one thing this register has consistently credited Dermatica for — printing the concentrations on the page you buy from — is absent here. No active is named. No strength is given. There is no ingredients section at all. And the page's own description of the problem is one no topical can fix.

There is a real reason to hesitate. Read the finding before you buy.

Dermatica / Rosacea Treatment

Ivermectin 1% and metronidazole 0.75% — the two best-evidenced topicals for rosacea, at their approved strengths, with the retinoid correctly left out. The best pool this company builds. The headline above it promises to clear rosacea for good, which is not a thing that can be done.

Worth buying for a specific person with a specific problem. Read who.

Ro / Custom Rx Treatment

'Compounded medication. Not FDA-approved.' sits directly under the price, and the safety information behind it is the most complete in this register — pregnancy, side effects, titration, interactions, and how to report an adverse event to the FDA. Seven ingredients are named. Not one carries a concentration.

Worth buying for a specific person with a specific problem. Read who.

Obagi / Nu-Derm Clear

The first manufactured prescription drug in this register rather than a compounded blend, and it shows: hydroquinone USP 4% stated as 40 mg/g, a full inactive list, real contra-indications, and the best sunscreen sentence anyone here has written. Two things are in neither the page nor the label — ochronosis, and the fact that the FDA has not found this drug safe and effective.

Worth buying for a specific person with a specific problem. Read who.

Sesame / Skincare Rx

The first thing in this register that sells no product at all. $59 a month buys a video visit with a named clinician you choose, and a prescription to your own pharmacy — which means the thing that arrives has a manufacturer's label on it. Every complaint we have made about unpublished formulas becomes structurally impossible. What you cannot find out is what the medicine will cost.

Worth buying for a specific person with a specific problem. Read who.

Alloy / M4 Face Cream Rx

A prescription estrogen cream for menopausal skin, with a full ingredient list published and a placebo-controlled trial claimed — both firsts here. It also has a section headed 'Safety Information' that contains no safety information: no side effects, no contra-indications, no pregnancy note, and no mention of breast cancer on a page selling topical estrogen to women over fifty.

There is a real reason to hesitate. Read the finding before you buy.

Alloy / M4 Body Treatment Rx

The concentration is published here — estriol 0.2% — along with the full ingredient list and the study's sample size. All three are improvements on the face cream. But this one goes on chest, arms and legs, and the page says nothing at all about absorption, dose per application, or who should not use it.

There is a real reason to hesitate. Read the finding before you buy.

Alloy / M4 Eye Cream Rx

The most completely specified product in this register — estriol 1%, palmitoyl pentapeptide-4 0.1%, acetyl hexapeptide-8 0.1%, a full ingredient list, and results labelled by whether an instrument or an assessor produced them. It is also five times the concentration of Alloy's body cream, applied to the thinnest skin on the face, millimetres from the meibomian glands, with no ophthalmic guidance of any kind.

There is a real reason to hesitate. Read the finding before you buy.

Alloy / Tretinoin Face Cream Rx

The first Alloy product to publish a fill weight and a dose — 30 grams, a pea-sized amount nightly — which finally makes one of their supply claims checkable. It is also a teratogen-class topical sold to perimenopausal women with no pregnancy warning, no side effects, no sunscreen instruction, and three strengths of which none is named.

There is a real reason to hesitate. Read the finding before you buy.

Alloy / Lash & Brow Serum Rx

The best page Alloy publishes and the only one that is not compounded: an FDA-approved generic named against its brand, at its approved concentration, with a real fill size and the first citations this company has printed. Two problems — the three-month supply is ten weeks by the manufacturer's own applicator count, and the periorbital fat atrophy on the approved label is mentioned nowhere.

Worth buying for a specific person with a specific problem. Read who.

Alloy / Rosacea Face Cream Rx

All three first-line rosacea topicals in one anhydrous, preservative-free, airless-pumped base, with every concentration published and the actuator volume given to a tenth of a millilitre. It is the best-made compounded product in this register. Nobody has ever trialled the combination, one active sits below its approved strength, and the page still does not say how often to use it.

Worth buying for a specific person with a specific problem. Read who.

Bausch Health / Renova

The only prescription anti-ageing product in this register whose own label tells you, in capital letters, that it does not reverse photoageing. It is also the only one that publishes what happened to the people who got the vehicle instead. Both facts are worth more than the drug.

Worth buying for a specific person with a specific problem. Read who.

Galderma / Tri-Luma

The triple combination every compounded melasma formula is imitating, with the numbers the imitations do not publish: 38% and 13% completely cleared at eight weeks across two trials. The label calls it short-term, says melasma usually recurs, and refuses to be a maintenance product.

Buy it. The formula, the disclosure and the price all hold up.

Bausch Health / Altreno

Tretinoin at a full 0.05% in a lotion carrying sodium hyaluronate, soluble collagen and glycerin — and the trial data show why that matters: dryness in 4% of users, stinging in 3%. This is what happens when a manufacturer treats the vehicle as part of the dose.

Buy it. The formula, the disclosure and the price all hold up.

Bausch Health / Arazlo

The strongest topical retinoid result in this register — 25.5% and 29.6% success at twelve weeks — attached to the worst price and an absolute contraindication in pregnancy that requires a negative test before you start.

Worth buying for a specific person with a specific problem. Read who.

Bausch Health / Retin-A Micro

Four published strengths, a porous polymer reservoir that meters the drug out over hours, and a titration ladder printed on the carton. Two of the four rungs have no efficacy trial and no pharmacokinetic study of their own, and the label says so.

Worth buying for a specific person with a specific problem. Read who.

Sun Pharmaceutical / Winlevi

The first topical androgen receptor inhibitor — the drug adult women with hormonal acne have been waiting for, with irritation rates no worse than its own vehicle. Then read the storage line: discard one month after opening, on a tube that costs five hundred dollars.

Worth buying for a specific person with a specific problem. Read who.

Galderma / Soolantra

Two trials, 1,371 subjects, a 65% reduction in inflammatory lesions and roughly two in five reaching clear or almost clear — and a safety database of 519 people who used it for a year. It is the best-evidenced single topical for papulopustular rosacea, and the reference the compounded versions are quietly diluting.

Buy it. The formula, the disclosure and the price all hold up.

Mayne Pharma / Rhofade

A vasoconstrictor for the redness of rosacea, and the only product in this register whose own registration trials show fewer than one user in five reaching the endpoint. It does not treat the disease. It constricts the vessels for part of a day, every day, for as long as you keep applying it.

There is a real reason to hesitate. Read the finding before you buy.

LEO Pharma / Finacea Foam

The only registration programme in this entire register whose subjects had a mean age of 50.6 — which is to say, the only trial population that looks like the people this site is written for. It also happens to be the cheapest prescription in the register.

Buy it. The formula, the disclosure and the price all hold up.

Nurx / Prescription Skincare

Every concentration, every container size, every price and an explicit statement that the compounded formulas are not FDA approved — all on the page you buy from. It is the disclosure standard this register has been asking nine other companies for. Now read what is in the Dark Spots Formula.

Worth buying for a specific person with a specific problem. Read who.

Dear Brightly / Night Shift Rx

A water-free silicone elastomer base with the full ingredient list published, a tretinoin range printed on the page, and a mandatory auto-refill plan justified by a claim about retinisation that the company's own shipping schedule contradicts.

Worth buying for a specific person with a specific problem. Read who.

Skin + Me / The Daily Doser

The only product in this register that solves the dose problem mechanically: a twist-and-click dispenser that meters one evening's cream and will not give you two. The seven-active pool is published in full, the base creams are published to INCI level, and the concentrations still arrive after you have paid.

Worth buying for a specific person with a specific problem. Read who.

Allergan / Latisse

It works, unambiguously — 78% of users versus 18% on vehicle at sixteen weeks. It can also permanently darken your iris and hollow the fat pad behind your upper eyelid. Both facts are on the same label, which is exactly why this review exists.

Worth buying for a specific person with a specific problem. Read who.

Galderma / Mirvaso

The other approved treatment for rosacea redness, and on paper roughly twice as effective as the one at R-41. Its own label also records subjects whose erythema came back worse than it started. That sentence is the whole review.

There is a real reason to hesitate. Read the finding before you buy.

Galderma / Oracea

An oral tetracycline deliberately dosed below the concentration that kills bacteria, with a label that forbids using it for infection and an 18-month study showing it leaves gut, skin, mouth and vaginal flora alone. This is the answer to every undosed antibiotic in this register.

Buy it. The formula, the disclosure and the price all hold up.

Arcutis / Zoryve Foam

The strongest efficacy result in this entire register — 79.5% treatment success against 58% on vehicle — with no local skin reaction reported above 1%, on the one very common midlife skin condition the register had entirely ignored. Then look at the price.

Worth buying for a specific person with a specific problem. Read who.

Galderma / Aklief

The same trial reports irritation in 7.5% of users and in 65% of users, depending on whether anyone asked. Both numbers are on the label, and the gap between them is the most useful thing in this review.

Worth buying for a specific person with a specific problem. Read who.

Almirall / Tazorac

The same molecule as R-37 at twice the strength and a tenth of the price, with irritation reported in 10 to 30% of users instead of 4 to 5%. It is also the only retinoid in this register with published data twelve weeks after people stopped using it.

Worth buying for a specific person with a specific problem. Read who.

Mayne Pharma / Epsolay

Benzoyl peroxide is the last thing you would put on rosacea skin. Sealed inside silica microcapsules that release it slowly, it produced 47.4% and 49.2% treatment success with application-site pain in 2% of users. This is the best formulation engineering in the register.

Buy it. The formula, the disclosure and the price all hold up.

Almirall / Seysara

A tetracycline engineered narrow, dosed by body weight, with a label that says efficacy beyond twelve weeks has not been established and that it must not be used for infection. The second considered answer in this register to the antibiotic problem — and the effect size is 22%.

Worth buying for a specific person with a specific problem. Read who.

Almirall / Klisyri

Five days of treatment, then you stop. Complete clearance of actinic keratoses in 44% and 54% of subjects against 5% and 13% on vehicle — and it answers a question R-34 raised and left hanging, because these are the photodamaged patients every anti-ageing trial excluded.

Buy it. The formula, the disclosure and the price all hold up.

Allergan / Aczone

The one acne label in this register that publishes a sex difference — women responded better than men, and it says so. The local reactions are indistinguishable from the vehicle. The effect is the smallest here, and the price depends entirely on whether you ask for the generic.

Worth buying for a specific person with a specific problem. Read who.

Bausch Health / Efudex

The incumbent R-54 is competing with: a chemotherapy agent applied to the face for two to four weeks, stopped when the skin reaches the erosion stage, unsightly for weeks afterwards, and around $36. Its label contains no efficacy figure of any kind.

Worth buying for a specific person with a specific problem. Read who.